The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.8 billion in 2021, at a CAGR of 6.3% from 2020 to 2028.
Continuous technological advancements in PCR technologies, Target diseases and genetic disorders; the development of miniaturized portable instruments, and incorporation of robotics; increasing investments, funds, and grants for research activities; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project are some of the factors that have supported long-term expansion for PCR Technologies Market.
PCR Technologies Market is segmented into technique, product type, application, end-user, and geography.
The technique segment is segmented into conventional PCR, real-time PCR, digital PCR, reverse transcription PCR, hot-start PCR, and multiplex PCR.
The product type segment is segmented into instruments, reagents & consumables, and software & services.
The application segment is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid detection, nucleic acid synthesis, standard validation/verification, diagnostic applications, and environmental applications.
Geographically, PCR Technologies Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East, and Africa, and South America and insights are provided for each region and major countries within the regions
Key players in PCR Technologies Market are Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (the US), bioMérieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany).
|
Report Feature |
Descriptions |
|---|---|
|
Market Revenue In 2021 |
USD 7.9 billion |
|
Growth Rate |
CAGR of 6.3% during the forecasting period, 2021-2028 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2028 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
|
Report Segmentation |
technique, product type, application, end-user, and geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (the US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (the US), bioMérieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany). |
|
Available Customization |
In addition to the market data for PCR Technologies Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement. |
.png)
.png)
.png)
.png)
.png)
.png)